medline.ch Onkologie Urologische Tumoren

	The evolving role of perioperative systemic therapy in bladder cancer. Cancer Atiq SO, Anker JF, Miller EJ, Karol AB, Mehrazin R, Sfakianos JP, Galsky MD. PMID: 42963929 [PubMed - indexed for MEDLINE]
	Comparison of HPV Antibodies Measured Prior to Diagnosis of Anal, Cervical, Oropharyngeal, Penile and Vaginal Cancers in the HPV Cancer Cohort Consortium. Int J Cancer Onwuka JU, Nobels MP, Kreimer AR, Schroeder L, Ferreiro-Iglesias A, Agalliu I, Albanes D, Cai Q, D'Souza G, Freedman ND, Giles GG, Hildesheim A, Huang WY, Hveem K, Langseth H, Milne RL, Ness-Jensen E, Schlecht NF, Tinker LF, Ursin G, Visvanathan K, Wassertheil-Smoller S, Weinstein SJ, Zheng W, Nygard M, Johansson M, Waterboer T, Clifford GM, Robbins HA. PMID: 42963861 [PubMed - as supplied by publisher]
	A multilevel intervention to improve adherence to prostate cancer active surveillance versus usual care: results from a pilot randomized controlled trial. BMC Cancer Chen JC, Skolarus TA, Furgal A, Rankin A, Wallner LP, Borza T, Hawley ST, Radhakrishnan A. PMID: 42963760 [PubMed - indexed for MEDLINE]
	PSMA Biology Through the Clinical Lens: Implications for Radioligand Therapy of Prostate Cancer with [(177)Lu]Lu-PSMA-617. Drugs Del Re M, Bauckneht M, Danesi R. PMID: 42963536 [PubMed - as supplied by publisher]
	CT-based multimodal fusion model for preoperative clear cell renal cell carcinoma grading: A multicenter study. Eur J Radiol Wu Y, Wang H, Liu C, Liu M, Yi H, Yu N, Jin B. PMID: 42962514 [PubMed - as supplied by publisher]
	Integrated single-cell and bulk RNA-Seq analysis reveals a LCR-related prognostic signature for precision prognostication and therapeutic stratification in clear cell renal cell carcinoma. Cancer Treat Res Commun Zhong W, Rao R, Zhang J, Cheng M, Wu X. PMID: 42962510 [PubMed - as supplied by publisher]
	Comprehensive Characterization of Crotonylation-Related Long Non-Coding RNAs Reveals a Prognostic Signature and Functional Landscape in Bladder Cancer. J Environ Pathol Toxicol Oncol Zhang W, Zheng K, Peng M, Zhang J, Wang X, Yuan Z. PMID: 42962197 [PubMed - indexed for MEDLINE]
	Prognostic value of the preoperative C-reactive protein-to-lymphocyte ratio in patients with non-metastatic clear cell renal cell carcinoma. PLoS One Qin M, Feng Z, Zhang C, Song W, Wang K, Chen Z. PMID: 42961929 [PubMed - indexed for MEDLINE]
	Reassessing the diagnostic value of spectral CT-derived parameters for pathological grading of urothelial carcinoma of the bladder. Abdom Radiol (NY) Wang X, Du S, Hu J, Liu X, Wen Z, Lin F. PMID: 42961642 [PubMed - as supplied by publisher]
	Malignant solitary fibrous tumour of the prostate with a concomitant prostatic adenocarcinoma - A case report and review of the literature. Indian J Pathol Microbiol Dhanasekaran V, Cima L. PMID: 42961580 [PubMed - indexed for MEDLINE]
	Histoplasma colonization of metastatic renal cell carcinoma (RCC) cells in a case of adrenal histoplasmosis involved by metastatic eosinophilic solid cystic RCC with rhabdoid differentiation. Indian J Pathol Microbiol Hota S, Chakrabarti S. PMID: 42961577 [PubMed - indexed for MEDLINE]
	PD-L1 Expression in muscle-invasive bladder carcinoma: correlation with tumor-stroma ratio and clinicopathological parameters. Indian J Pathol Microbiol Chaturvedi A, Nisam I, Mallya V, Mandal S, Singh CB. PMID: 42961563 [PubMed - indexed for MEDLINE]
	Enzalutamide alone or combined with other pharmacologic agents for metastatic castration-resistant prostate cancer: A systematic review and meta-analysis. J Oncol Pharm Pract Cruz Castillo Y, Chen Liang A, Samperio VM, Bentley A, Roberts Trinidad EO, Codreanu I, Dasanu CA. PMID: 42961340 [PubMed - as supplied by publisher]
	Impact of the Multimodal Protocol on the Outcomes of Cancer Patients Undergoing Radical Cystectomy. Rev Col Bras Cir Petry MA, Polakowski CB, Rabito EI, Kool R, Luz M, Pereira JL, Sato BMK, Lombardi RG, Tomasich FDS. PMID: 42961271 [PubMed - indexed for MEDLINE]
	The current landscape of bladder-sparing therapies in BCG-refractory high-risk nonmuscle-invasive bladder cancer. Curr Urol Gu Y, He W, Yu X, Jiang C, Zhang Z, Xu C, Zeng S. PMID: 42960368 [PubMed]
	Explainable artificial intelligence in prostate and bladder cancer: A review of imaging, digital pathology, molecular profiling, and clinical data. Curr Urol Diamantidis D, Tsakaldimis G, Smyrlis N, Chousein C, Kafalis C, Foutzitzi K, Deligeorgiou E, Panagiotopoulos N, Lailisidis S, Georgellis C, Giannopoulos S, Giannakopoulos S, Kalaitzis C. PMID: 42960345 [PubMed]
	4Kscore as a Pre-MRI Reflex Test for Men with PSA 1.80-2.99â€¯ng/ml in the GÃ¶teborg-2 Prostate Cancer Screening Trial. Eur Urol Open Sci Möller F, Josefsson A, Månsson M, Carlsson S, Lilja H, Spyratou V, Wallström J, Hugosson J, Arnsrud Godtman R. PMID: 42960148 [PubMed]
	Bipolar androgen therapy in castration-resistant prostate cancer: Biological rationale, clinical evidence, and future directions. Curr Urol Rival PM, Jiang J, Qu LG, O'Brien J, Gilmore P, Corcoran N. PMID: 42960082 [PubMed]
	Ultrasound with nerve stimulation versus ultrasound alone for obturator nerve block in transurethral resection of bladder tumor: A systematic review and meta-analysis. Saudi J Anaesth Hu Q, Gan L, Ouyang C, Peng L, Zhong C, Wang S. PMID: 42960054 [PubMed]
	Targeting lipid metabolism to overcome therapeutic resistance in renal cell carcinoma: Mechanisms and emerging strategies. Curr Urol Feng Y, Zhang S, Li J, Yue D, Wang Y. PMID: 42960049 [PubMed]

Artikel 1 - 20 / 182620

Seite 1 von 9131

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung